A retrospective comparative cohort study: concurrent versus consolidative immunotherapy with chemoradiotherapy in EGFR- or ALK-negative unresectable stage III non-small cell lung cancer.

Wu, Yonghui; Guo, Zhiyi; Meng, Lu; Fan, Rui; Gridelli, Cesare; Park, Henry S; Cao, Yajuan; Wang, Lixin

Wu, Yonghui; Guo, Zhiyi; Meng, Lu; Fan, Rui; Gridelli, Cesare; Park, Henry S; Cao, Yajuan; Wang, Lixin.

Affiliation

Wu Y; Department of Integrated Traditional Chinese and Western Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Guo Z; Graduate School of Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Meng L; Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Fan R; Department of Radiation Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Gridelli C; Department of Integrated Traditional Chinese and Western Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Park HS; Division of Medical Oncology, 'S. G. Moscati' Hospital, Avellino, Italy.
Cao Y; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
Wang L; Department of Integrated Traditional Chinese and Western Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.

Transl Lung Cancer Res ; 12(11): 2209-2218, 2023 Nov 30.

Article de En | MEDLINE | ID: mdl-38090516

Mots clés

Non-small cell lung cancer (NSCLC); anaplastic lymphoma kinase (ALK); chemoradiotherapy; epidermal growth factor receptor (EGFR); immunotherapy

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Transl Lung Cancer Res Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google